loading page

Sars-CoV-2 Infection in a Neutropenic Pediatric Patient with Leukemia: Addressing the need for universal guidelines for treatment of Sars-CoV-2 positive, immunocompromised patients
  • Anastasia Schied,
  • Erin Trovillion,
  • Amaran Moodley
Anastasia Schied
University of California San Diego
Author Profile
Erin Trovillion
University of California San Diego
Author Profile
Amaran Moodley
University of California San Diego
Author Profile

Abstract

In December 2019, a novel coronavirus (Sars-CoV-2 ) emerged from Wuhan, Hubei province, China, and has spread worldwide, with more than 4 million confirmed cases[1,2,3]. Available literature on the clinical characteristics and natural history of pediatric patients infected with Sars-CoV-2 is limited and less has been established regarding guidelines for the treatment of immunocompromised pediatric patients. This is a case report on the clinical course and management of a 6 year old female with acute lymphoblastic lymphoma with Sars-CoV-2. The goal is to highlight the need for management guidelines in the care of pediatric cancer patients with Sars-CoV-2.